STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on July 23, 2026

2 hours ago

Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026

Indeterminate GlobeNewswire

3 hours ago

Oriental Culture Holding LTD. Announces Strategic Transition to Supporting Services for Third Party Art and Collectible Platforms

Indeterminate GlobeNewswire

3 hours ago

Merlin to Report Second Quarter 2026 Results on August 13, 2026

Indeterminate GlobeNewswire

3 hours ago

VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience

Indeterminate GlobeNewswire

3 hours ago

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

3 hours ago

Turtle Beach Corporation to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Indeterminate GlobeNewswire

3 hours ago

Codexis Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire

3 hours ago

DoubleVerify to Announce Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

3 hours ago

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Indeterminate GlobeNewswire

3 hours ago

Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés

Indeterminate GlobeNewswire

3 hours ago

Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Indeterminate GlobeNewswire

3 hours ago

Silvaco Announces Date of Second Quarter 2026 Financial Results Conference Call

Indeterminate GlobeNewswire

3 hours ago

Rigetti Computing to Report Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

Indeterminate GlobeNewswire

3 hours ago

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Indeterminate GlobeNewswire

3 hours ago

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease

Indeterminate GlobeNewswire

3 hours ago

Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Indeterminate GlobeNewswire

3 hours ago

Digital Realty Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

3 hours ago

AppFolio, Inc. Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

Indeterminate GlobeNewswire

3 hours ago

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

Indeterminate GlobeNewswire